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Abstract
Kidney cancer, with 4% of all malignancies, is one of the most common malignancies occurring among in adults. In Saudi Arabia, kidney cancer 
comprises 2.3% of all cancers, and its incidence has increased by 33%. Partial nephrectomy (PN) is considered as the gold standard for T1 renal 
masses. 
In this retrospective study, we did a chart review for all patients who underwent PNs between April 2013 and February 2019. Data comprised pre-
sentation, tumor size, type of procedure (open vs. laparoscopic vs. robotic), and intra- and post-operative complications. Chi-square, ANOVA, 
and cross-tabulation were done using SPSS software. P > 0.05 was considered significant. Approval was obtained from the institutional review 
board of King Abdullah International Medical Research Center.
In all, 69 patients were identified: 26 (37.7%) males and 43 (62.3%) females, with mean age = 54.53 ± 13.21 years; mean body mass index = 
32.36 ± 7.03, and mean tumor size = 3.7 ± 1.72 cm. In terms of presentation, most patients (50, 72.4%) presented incidentally as opposed to 
symptomatic presentation. Of these patients, 18 (26.1%) underwent open partial nephrectomy (OPN), 29 (42%) laparoscopic partial nephrec-
tomy (LPN), and 22 (31.9%) robotic partial nephrectomy (RPN). On comparing minimally invasive surgery (MIS) PN with OPN, we found that 
OPN had more blood loss and a longer hospital stay but a shorter operating room (OR) time.
Results of PN irrespective of the procedure type, whether it was OPN, LPN, or RPN, were similar if  performed by experienced surgeons. 
However, open procedures involved a higher blood loss, more operative time, and longer hospital stay when compared with minimally invasive 
techniques.
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Introduction
In managing organ-confined tumors, radical resection has 
been the preferred management. In renal cell carcinoma 
(RCC), radical nephrectomy was the gold standard in 
approaching solid renal masses. However, with the devel-
opment of minimally invasive surgery (MIS), laparoscopic 
and robotic approaches have been used for treating RCC (1). 
Nephron sparing surgery, partial nephrectomy (PN), has 
emerged in treating solid renal masses of 4–7 cm in diame-
ter or clinical T1a and T1b renal masses. According to cur-
rent guidelines of the American Urological Association and 
European Urological Association, PN is the standard of care 
for small renal masses, with robotic partial nephrectomy 
(RPN) and laparoscopic partial nephrectomy (LPN) being 
valid MIS options (2–4). PN has the advantage of preserving 
renal function, and thus decreasing the risk of developing 
metabolic and cardiovascular disorders (5).
A nationwide study was conducted in the United States 
from 2008 to 2014 to examine LPN versus RPN. It estab-
lished that robotic approach has become a more favorable 
MIS option (23.9% vs. 92%) (6). Nevertheless, controversy 
exists in terms of outcomes, whether RPN or LPN is supe-
rior. Recent meta-analysis comparing both the techniques 
has indicated that RPN has more favorable outcomes in 
terms of conversion rates, effect on renal function, shorter 
hospital stay, and lower ischemic time (7).
In Saudi Arabia, studies regarding RCC and its manage-
ment are rare. In the present study, we aimed to describe 
trends in PN management at our tertiary care referral center 
of King Abdullah International Medical Research Center, 
Riyadh, and compared the three approaches (RPN, LPN, 
and open partial nephrectomy [OPN]) in terms of outcomes, 
complications, and disease status on last follow-up as an ini-
tial local experience.
Methods
Approval for the study was obtained from the Institutional 
Review Board (IRB) of King Abdullah International Med-
ical Research Center. We did a retrospective chart review of 
all patients who had undergone PN between April 2013 and 
February 2019. At our tertiary care referral center, depend-
ing on factors pertaining to patient and surgeon’s expe-
rience and preference, PN is done either as OPN, LPN, or 
RPN using Da Vinci Si and Xi console robots. Patients were 
grouped according to the procedure type. Mostly, patients 
having clinical T1a and T1b renal masses undergo PN. Data 
variables collected included presentation, patient demo-
graphics (age, gender, body mass index [BMI], and size of 
tumor), RENAL nephrometry score (recorded by an experi-
enced single reviewer), procedure type (OPN, LPN, or RPN), 
operative factors (operative time, ischemic time, estimated 
blood loss as declared by the surgeon at the end of the proce-
dure, hospital stay, and perioperative blood transfusion), and 
complications; all these variables were classified using the 
Clavien grading system. Also, patients’ follow-up short-term 
(1–3 months) and long-term (6–12 months) data regarding 
hemoglobin, estimated glomerular filtration rate (eGFR), 
creatinine, local recurrence, presence of metastasis, whether 
chemotherapy provided, and death were considered. Chi-
square, ANOVA, and cross-tabulations were done to com-
pare groups using SPSS software. P > 0.05 was considered 
significant. 
Results
In all, 69 patients, including 26 (37.7%) males and 43 (62.3%) 
females were identified, with the following parameters: 
mean age, 54.53 ± 13.21 years; mean BMI, 32.36 ± 7.03; 
and mean tumor size, 3.7 ± 1.72 cm (Table 1). In terms of 
presentation, most patients (N = 50, 72.4%) presented inci-
dentally as opposed to symptomatic presentation with flank 
pain (14, 20.35%), hematuria (5, 7.2%), and dysuria (2, 2.9%) 
(Table 1). Most common comorbidity observed was hyperten-
sion (HTN) (34, 49.3%), followed by diabetes mellitus (DM) 
(30, 43.5%) and dyslipidemia (DLP) (20, 29%). Thirty-two 
(56.1%) patients had right-side tumor and 25 (43.9%) had 
tumor on their left side (Table 1); 18 patients (26.1%) under-
went OPN, 29 (42%) LPN, and 22 (31.9%) RPN. Among 
these, 8 (11.6%) LPN procedures were converted to OPN; 
however, no RPN was converted to OPN (Table 1). Positive 
surgical margin score determined was 4 (22.2%) in OPN, 2 
(6.9%) in LPN, and 7 (13%) in RPN; this difference was not 
statistically significant (P = 0.072), as the overall positive sur-
gical margin rate was 13 (18.8%). No statistical significance 
was found between three PN modalities in terms of blood loss 
and operative time (P = 0.141 and 0.872, respectively). How-
ever, we found that OPN had more blood loss and a longer 
hospital stay but a shorter operating room (OR) time when 
compared with MIS PN, although this observation was not 
statistically significant (P > 0.05). Regarding hospital stay, we 
found that RPN had the least hospital stay between modali-
ties, followed by OPN and LPN (P = 0.03) (Table 2). When 
comparing tumor complexity using the RENAL nephrome-
try score, we found that higher scores were used in OPN, fol-
lowed by RPN and LPN; this was statistically significant (P = 
0.02). In addition, ischemic time was longer in OPN, followed 
by LPN and RPN; this difference was also statistically signif-
icant (P = 0.014) (Table 2). The most common histological 
subtype of RCC found was clear cell in 41 patients (59.4%), 
followed by chromophobe in 10 (14.55), papillary in 6 (8.7%), 
oncocytoma in 4 (5.8%), and angiomyolipoma in 4 patients 
(5.8%). Regarding pathological grades, the most common, 
according to Fuhrman classification, was grade 2 in 33 
patients (47.8%), followed by grade 3 in 10 (14.5%), grade 1 
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Table 1: Baseline characteristics of patients.
Variables N (%)
Site Right side 32 (56.1)
Left side 25 (43.9)
Gender Male 26 (37.7)
Female 43 (62.3)
Procedure type Open 18 (26.1)
Laparoscopic 29 (42)
Robotic 22 (31.9)
Complications Converted to radical 1 (1.8)
Converted to open 8 (11.6)
Transfuse packed RBC 5 (7.2)
Presentation Incidental 50 (72.4%)
Hematuria 5 (7.2)
Flank pain 14 (20.3)
Dysuria 2 (2.9)




















Lung metastasis 1 (1.4)
Local recurrence 2 (2.9)
On chemotherapy 1 (1.4)
HTN: hypertension; DM: diabetes mellitus; DLP: dyslipidemia; 
CHF: congestive heart failure; CAD: coronary artery disease.
Table 2: Baseline mean values of patients. 
Mean values 
BMI mean–median ± SD 32.36–31.96 ± 7.03
Age mean (years)–median ± SD 54.53–53 ± 13.21
Hospital stay mean– 
median ± SD
6.88– 6 ± 4.939




OR time (min.) mean– 
median ± SD
253.59–245 ± 63.66
Tumor size (cm) mean– 
median ± SD
3.7–3.5 ± 1.72
RENAL nephrometry score 
mean–median ± SD
6.23–7 ± 2.38
Ischemic time (min.) mean–
median ± SD
22.32–20.05 ± 10.5
in 9 (13%), and grade 4 in 1 patient (1.4%). As for Clavien 
grading for complications is concerned, no statistically sig-
nificant difference was found (P > 0.05) between modalities; 
however, it was observed that OPN had one grade-2 and one 
grade-4 complications as opposed to LPN, where only one 
patient had grade-1 complications, the rest had no compli-
cations. In the case of RPN, three patients had grade-1 and 
one had grade-2 complications, and the rest had no compli-
cations. No statistically significant difference was observed 
(P = 0.830) between pre-operative and day 1 post-operative 
hemoglobin values, which were measured for all patients, 
although it was observed that difference in mean hemoglobin 
values was highest in RPN at 19.72 mg/dL, followed by OPN 
at 18.22 mg/dL and LPN at 15.82 mg/dL. On follow-up, car-
ried out at 6–12 months, we were able to measure estimated 
glomerular filtration rate (eGFR), creatinine, and blood urea 
nitrogen (BUN) levels; no statistically significant difference 
was found in eGFR and creatinine values between groups 
(P = 0.563 and 460, respectively). For BUN levels, statistical 
difference was observed between the groups (P = 0.024); the 
highest increase in BUN was observed in LPN group with a 
mean increase of 6.39 ± 21.70 mg/dL. Concerning patient sta-
tus, we had one (1.4%) patient mortality, two patients (2.9%) 
had local recurrence, and one (1.4%) had lung metastasis, for 
which chemotherapy was commenced.
Discussion
For managing small renal masses, PN has replaced radical 
resection as the standard of care (3, 4). PN offers an excellent 
oncological control of RCC and is popular among urologists 
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Table 3: Comparing groups for pre-operative and post-operative follow-up mean values for hemoglobin (Hgb), glomerular 
filtration rate (GFR), creatinine, and blood urea nitrogen (BUN), and mean values of operating room (OR) time, blood loss, 
hospital stay, tumor size, RENAL nephrometry score, and Ischemic time. 
Open Laparoscopic Robotic P-value 
Hgb mean difference ± SD post-op day 1 18.22 ± 13.24 15.82 ± 22.47 19.72 ± 14.56 0.830
eGFR difference ± SD long-term 6–12 months 15.27 ± 15.27 10.48 ± 35.06 10.72 ± 32.80 0.563
Creatinine difference ± SD long-term 6–12 months 11.77 ± 44.30 22.93 ± 41.56 30.53 ± 31.78 0.460
BUN difference ± SD long-term 6–12 months 1.30 ± 2.22 6.39 ± 21.70 1.95 ± 2.77 0.024
OR time (min) ± SD 225.39 ± 55.93 271.29 ± 63.12 254.14 ± 66.07 0.872
Blood loss (mL) ± SD 542.22 ± 720.67 334.14 ± 564.01 245.45 ± 212.04 0.141
Hospital days ± SD 7.61 ± 5.00 7.62 ± 6.22 5.32 ± 1.83 0.031
Tumor size (cm) ± SD 4.23 ± 1.72 3.56 ± 1.93 3.45 ± 1.48 0.973
RENAL nephrometry score ± SD 7.22 ± 1.39 5.41 ± 2.89 6.50 ± 1.94 0.020
Ischemia time (min) ± SD 27.87 ± 11.51 22.93 ± 13.13 19 ± 4.89 0.014
because this nephron sparing procedure entails higher sur-
vival rates and is less morbid than radical resection. With 
increased incidental diagnoses, PN has proved to be an 
acceptable approach for small RCC (8, 9). Nevertheless, PN 
carries the risk of local disease recurrence, which has been 
reported in as high as 10% patients in a larger series  (10). 
This has come down with the development of RPN, and 
according to a recent meta-analysis, RPN has lowered the 
incidence of positive surgical margins as well as have more 
favorable perioperative results, thus enabling to effectively 
manage complex tumors in an MIS setting (7). Lack of stud-
ies addressing the management of small renal masses with 
different modalities in Saudi Arabia has encouraged us to 
report our local experiences.
In this study, we demonstrated the initial Saudi experience 
of managing RCC in 69 patients treated with PN at tertiary 
care center, and compared OPN, LPN, and RPN. Although 
larger number series and long follow-up outcomes were 
required, PN offered excellent oncological control of small 
RCC tumors, and with the use of MIS, it offered favorable 
outcomes. In our patient population, the overall positive sur-
gical margin rate was 18.8%, which was higher than what most 
series have reported (0–10%) irrespective of PN modality (11, 
12). The impact of having a positive surgical margin has been 
reported by some larger series, with insignificant or no impact 
on metastasis or recurrence (13). High positive margin rate 
in our study population may be attributed to factors such as 
large mean tumor size, which was less than 4 cm with a mean 
size of 3.7 cm. Yossepowitch et al. (14) have reported that a 
larger tumor size is associated with lower positive margin rates 
in univariate and multivariate analyses. Positive surgical mar-
gin rate is affected by factors such as surgeon experience, use 
of intraoperative ultrasound, frozen section, and wide exci-
sion if margin integrity is questioned interop (15).
In our study population, no effect was observed on renal 
function between all groups except elevated BUN in LPN 
group. Nonetheless, all the observed parameters across three 
groups didn’t show any clinically significant decline in renal 
function on follow-up, which was >25% decline in GFR 
from baseline according to recommendations and guide-
lines  (13). However, to accurately measure the effect of PN 
on renal function, renal arterial resistive index measurement 
is required through duplex ultrasonography (16).
Our study is distinctive in its finding that PN outcomes are 
comparable across all modalities. This is especially remark-
able when looking at LPN, as this approach is known to 
be technically challenging, has a lengthy learning curve to 
master, and was the most common approach used in our 
study (17). On the other hand, RPN is relatively new in Saudi 
 Arabia and not many centers have access to a surgical robot, 
although this choice, according to prospective studies, has 
proven to be a viable, safer, and more effective option (18). 
Hopefully, with more RPN cases and introduction of surgi-
cal robots at more centers, results may be achieved compara-
ble to high-volume centers across the world.
We compared all three modalities of PN in terms on isch-
emic time and RENAL nephrometry score. According to 
a recent systematic review, ischemic time during PN has no 
effect on renal function unless it is longer than the limit of 
25 min (19). In our study, between three modalities of PN, we 
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established that OPN had the longest ischemic time, followed 
by LPN and RPN. This finding contradicts the US retrospec-
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higher blood loss, higher OR time, and longer hospital stay 
when compared with minimally invasive techniques. With our 
modest experience, we have demonstrated that PN is a feasible 
option in all its approaches, but more experience is required to 
achieve results similar to that of high-volume centers.
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